Cancer Treatment & Beta Glucan

Beta Glucan supports cancer patients by enhancing immune response during chemotherapy, for a stronger recovery journey.

The Research

200,000 Peer-Reviewed Studies Published

This extensive research highlights the significant scientific interest in understanding the biological and immunological effects of glucan, including its potential applications in cancer treatment and immune system support.

Clinical Trials

Over 200 Ongoing Trials Underway

40+ years of scientific studies and at least 200 ongoing clinical trials related to beta-glucan and cancer in the United States and several European countries.

The Findings

Enhancing The Immune Response

Beta-glucan has significant potential in supporting cancer treatment by enhancing the immune response and potentially improving outcomes for cancer patients.

Article Summary

Skin cancer is the abnormal growth of skin cells that is often developed on skin that has been exposed to the sun. It stems from various causes, with ultraviolet (UV) exposure being a prime factor. When UV rays from the sun or artificial sources like tanning beds penetrate the skin, they can damage cell DNA, leading to abnormal growths. However, this form of cancer can also occur on skin that is not exposed to sunlight often. (1) (2)

Article Highlights

Skin cancer signs include suspicious skin changes, red patches, and persistent sores.
There are three major types of skin cancer: melanomas, basal cell carcinoma (BCC), and squamous cell carcinoma (SCC).
UV light damages DNA, leading to mutations and impaired immune responses.
A yeast sugar called β-glucan was used in a medical study to see if it could help mice with skin cancer.
β-glucan boosts chemotherapy's effectiveness against melanoma.
Shields blood cells from cancer-induced damage.
Lacks harmful effects on blood cells, protecting the immune system
β-Glucan can enhance other cancer treatments as an effective adjuvant.